Geoff Meacham

Stock Analyst at B of A Securities

(3.61)
# 984
Out of 4,497 analysts
156
Total ratings
52.1%
Success rate
4.81%
Average return

57 Stocks

Lyell Immunopharma
Jun 27, 2024
Maintains: Buy
Price Target: $9$6
Current: $1.56
Upside: +284.62%
BridgeBio Pharma
Jun 25, 2024
Maintains: Buy
Price Target: $50$42
Current: $26.19
Upside: +60.37%
Eli Lilly
Jun 24, 2024
Maintains: Buy
Price Target: $1,000
Current: $857.47
Upside: +16.62%
Avidity Biosciences
Jun 13, 2024
Maintains: Buy
Price Target: $40$45
Current: $45.12
Upside: -0.27%
Apogee Therapeutics
May 10, 2024
Initiates: Buy
Price Target: $80
Current: $47.50
Upside: +68.42%
Johnson & Johnson
Apr 17, 2024
Maintains: Neutral
Price Target: $180$170
Current: $154.69
Upside: +9.90%
Regeneron Pharmaceuticals
Apr 12, 2024
Maintains: Underperform
Price Target: $710$720
Current: $1,063.60
Upside: -32.31%
Royalty Pharma
Apr 12, 2024
Maintains: Buy
Price Target: $40$38
Current: $28.14
Upside: +35.04%
Biogen
Apr 12, 2024
Maintains: Neutral
Price Target: $280$260
Current: $226.40
Upside: +14.84%
BioXcel Therapeutics
Mar 13, 2024
Maintains: Buy
Price Target: $8$7
Current: $1.17
Upside: +498.29%
Janux Therapeutics
Mar 13, 2024
Maintains: Buy
Price Target: $24$48
Current: $44.68
Upside: +7.43%
Kymera Therapeutics
Jan 3, 2024
Downgrades: Neutral
Price Target: $45$30
Current: $43.10
Upside: -30.39%
Bristol-Myers Squibb Company
Jan 3, 2024
Downgrades: Neutral
Price Target: $68$60
Current: $42.64
Upside: +40.71%
IGM Biosciences
Dec 15, 2023
Downgrades: Neutral
Price Target: $8
Current: $10.74
Upside: -25.51%
Amgen
Oct 11, 2023
Reinstates: Neutral
Price Target: $290
Current: $331.29
Upside: -12.46%
Neumora Therapeutics
Oct 10, 2023
Initiates: Buy
Price Target: $18
Current: $11.28
Upside: +59.57%
Vir Biotechnology
Sep 8, 2023
Downgrades: Neutral
Price Target: $23$14
Current: $10.03
Upside: +39.58%
Gilead Sciences
Sep 8, 2023
Upgrades: Buy
Price Target: $88$95
Current: $72.56
Upside: +30.93%
CureVac
Aug 21, 2023
Maintains: Underperform
Price Target: $10$8
Current: $3.67
Upside: +117.98%
Rani Therapeutics Holdings
Aug 21, 2023
Maintains: Buy
Price Target: $19$17
Current: $3.08
Upside: +451.95%
Turnstone Biologics
Aug 15, 2023
Initiates: Buy
Price Target: $18
Current: $2.37
Upside: +659.49%
Moderna
Aug 4, 2023
Maintains: Neutral
Price Target: $175$150
Current: $121.14
Upside: +23.82%
BioMarin Pharmaceutical
Jul 21, 2023
Maintains: Buy
Price Target: $200$185
Current: $84.09
Upside: +120.00%
Acumen Pharmaceuticals
Jul 20, 2023
Reinstates: Buy
Price Target: $14
Current: $2.87
Upside: +387.80%
Pfizer
Apr 21, 2023
Maintains: Neutral
Price Target: $50$45
Current: $29.97
Upside: +50.15%
Amylyx Pharmaceuticals
Jan 5, 2023
Initiates: Buy
Price Target: $50
Current: $2.02
Upside: +2,375.25%
Merck & Co.
Jan 4, 2023
Upgrades: Buy
Price Target: $110$130
Current: $125.77
Upside: +3.36%
AbbVie
Dec 14, 2022
Maintains: Neutral
Price Target: $162$165
Current: $172.32
Upside: -4.25%
Inovio Pharmaceuticals
Nov 1, 2022
Downgrades: Underperform
Price Target: $24
Current: $10.07
Upside: +138.33%
Omeros
Jun 8, 2022
Downgrades: Neutral
Price Target: $12$4
Current: $4.88
Upside: -18.03%
Kiniksa Pharmaceuticals
Dec 29, 2021
Maintains: Buy
Price Target: $37$34
Current: $21.23
Upside: +60.15%
Vaxxinity
Dec 6, 2021
Initiates: Buy
Price Target: n/a
Current: $0.11
Upside: -
Tyra Biosciences
Oct 11, 2021
Initiates: Buy
Price Target: n/a
Current: $19.73
Upside: -
Century Therapeutics
Jul 13, 2021
Initiates: Buy
Price Target: n/a
Current: $2.50
Upside: -
Y-mAbs Therapeutics
May 7, 2021
Upgrades: Buy
Price Target: $56
Current: $11.59
Upside: +383.18%
Esperion Therapeutics
Jan 15, 2021
Downgrades: Neutral
Price Target: n/a
Current: $2.39
Upside: -
Galecto
Nov 23, 2020
Initiates: Buy
Price Target: n/a
Current: $0.56
Upside: -
PMV Pharmaceuticals
Oct 20, 2020
Initiates: Buy
Price Target: n/a
Current: $1.56
Upside: -
CRISPR Therapeutics AG
Oct 5, 2020
Initiates: Buy
Price Target: n/a
Current: $54.56
Upside: -
MeiraGTx Holdings
Sep 15, 2020
Reinstates: Buy
Price Target: n/a
Current: $4.42
Upside: -
Sangamo Therapeutics
Sep 8, 2020
Reinstates: Buy
Price Target: n/a
Current: $0.40
Upside: -
Poseida Therapeutics
Aug 4, 2020
Initiates: Buy
Price Target: n/a
Current: $3.06
Upside: -
Puma Biotechnology
Jun 25, 2020
Reinstates: Underperform
Price Target: n/a
Current: $3.66
Upside: -
REGENXBIO
Jun 25, 2020
Reinstates: Buy
Price Target: n/a
Current: $12.58
Upside: -
Genfit
Jun 25, 2020
Initiates: Underperform
Price Target: n/a
Current: $4.16
Upside: -
United Therapeutics
Mar 1, 2019
Maintains: Underweight
Price Target: n/a
Current: $329.16
Upside: -
DBV Technologies
Dec 20, 2018
Downgrades: Equal-Weight
Price Target: $60$16
Current: $0.84
Upside: +1,804.76%
PTC Therapeutics
Nov 6, 2018
Maintains: Equal-Weight
Price Target: n/a
Current: $32.63
Upside: -
Gritstone bio
Oct 23, 2018
Initiates: Overweight
Price Target: n/a
Current: $0.65
Upside: -
Neurocrine Biosciences
Aug 1, 2018
Maintains: Overweight
Price Target: n/a
Current: $145.69
Upside: -
Prothena Corporation
May 21, 2018
Downgrades: Underweight
Price Target: n/a
Current: $23.58
Upside: -
Zymeworks
May 11, 2018
Upgrades: Equal-Weight
Price Target: n/a
Current: $9.78
Upside: -
Ironwood Pharmaceuticals
May 3, 2018
Maintains: Equal-Weight
Price Target: n/a
Current: $6.72
Upside: -
Incyte
Apr 5, 2018
Maintains: Overweight
Price Target: n/a
Current: $65.87
Upside: -
Biohaven Pharmaceutical Holding Company
Apr 5, 2018
Downgrades: Equal-Weight
Price Target: n/a
Current: $35.98
Upside: -
Vertex Pharmaceuticals
Feb 1, 2018
Maintains: Overweight
Price Target: n/a
Current: $491.57
Upside: -
Alnylam Pharmaceuticals
Nov 8, 2017
Maintains: Overweight
Price Target: n/a
Current: $237.83
Upside: -